Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression

Rosiglitazone up-regulates caveolin-1 levels and has neuroprotective effects in both chronic and acute brain injury. Therefore, we postulated that rosiglitazone may ameliorate diffuse axonal injury via its ability to up-regulate caveolin-1, inhibit expression of amyloid-beta precursor protein, and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yong-lin, Song, Jin-ning, Ma, Xu-dong, Zhang, Bin-fei, Li, Dan-dong, Pang, Hong-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962592/
https://www.ncbi.nlm.nih.gov/pubmed/27482223
http://dx.doi.org/10.4103/1673-5374.184493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962592/
https://www.ncbi.nlm.nih.gov/pubmed/27482223
http://dx.doi.org/10.4103/1673-5374.184493

Ejemplares similares